Naltrexone, but not atropine or yohimbine, antagonizes suppression of formalin-induced spinal sensitization by intrathecal nociceptin

Life Sciences

Volumn 63, Issue 11, 1998, Pages A167-A173

  Hao, Shuanglin ^a   Ogawa, Hidemichi ^a  

^a NONE

Author keywords

Atropine; Formalin test; Naltrexone; Nociceptin; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATROPINE; FORMALDEHYDE; MUSCARINIC RECEPTOR; NALTREXONE; NOCICEPTIN; OPIATE RECEPTOR; YOHIMBINE;

AMINO ACID SEQUENCE; ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG SENSITIZATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032493666     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00359-2     Document Type: Article

References (27)

1. 1. JE. LACHOWICZ, Y. SHEN, F. J.J.R. MONSMA, D.R. SIBLEY, J. Neurochem, 64 34-40 (1995)
2. 2. J.C. MEUNIER , C. MOLLEREAU, L. TOLL, C. SUAUDEAU, C. MOISAND, P. ALVINERIE, J.L BUTOUR, J.C. GUILLEMOT, P. FERRARA, B. MONSARRAT, H. MAZARGUIL, G. VASSART, M. PARMENTIER, J. COSTENTIN, Nature, 377 532-5 (1995)
3. 3. R.K. REINSCHEID, H.P. NOTHACKER, A. BOURSON, A. ARDATI, R.A. HENNINGSEN, J.R. BUNZOW,D.K. GRANDY, H. LANGEN, F.J. Jr. MONSMA, O. CIVELLI, Science, 270 792-4 (1995)
4. 4. J.L. MONTIEL, F. COMILLE, B.P. ROQUES, F. NOBLE, J Neurochem, 68 354-61 (1997).
5. 5. J.R. BUNZOW, C. SAEZ, M. MORTRUD, C. BOUVIER, J.T. WILLIAMS, M. LOW, D.K. GRANDY, FEBS Letter, 347 284-8 (1994).
6. 6. C. MOLLEREAU, M. PARMENTIER, P. MAILLEUX, J.L. BUTOUR, C. MOISAND, P. CHALON, D. CAPUT, G. VASSART, J.C MEUNIER, FEBS Letter, 341 33-8 (1994)
7. 7. M.J. WICK, S.R. MINNERATH, X. LIN, R. ELDE, P.Y. LAW, H.H. LIH, Molecular Brain Res, 27 37-44 (1994).
8. 8. M.A. KING, G.C. ROSSI, A.H. CHANG, L. WILLIAMS, G.W. PASTERNAK, Neurosci. Letts, 223 113-6 (1997).
9. 9. T. YAMAMOTO, N. NOZAKI-TAGUCHI, S. KIMURA, Neurosci. Letts, 224 107-10 (1997).
10. 10. X.J. XU, J.X. HAO, Z. WIESENFELD-HALLIN, Neuroreport, 7 2092-4 (1996)
11. 11. J.X. HAO, Z. WIESENFELD-HALLIN, X.J. XU, Neurosci Letts, 223 49-52 (1997).
12. 12 L.C. STANFA, V. CHAPMAN, N. KERR, A.H. DICKENSON, Br. J. Pharmacol, 118 1875-7 (1996).
13. 13. T.L. YAKSH, T.A. RUDY, Physio Behav, 17 1031-1036 (1976).
14. 14. A.H. DICKENSON, A.F. SULLIVAN, Pain, 30 349-60 (1987).
15. 15. A.H. DICKENSON, A.F. SULLIVAN, Neuropharmacology, 26 1235-8 (1987)
16. 16. X.W. WANG, K.M. ZHANG, S.S. MOKHA, J. Neurophysiol, 76 3568-72 (1996)
17. 17. E.S. FABER, J.P. CHAMBERS, R.H. EVANS, G. HENDERSON, Br. J. Pharmacol, 119189-90 (1996)
18. 18. G.C. ROSSI, L. LEVENTHAL, G.W. PASTERNAK, Eur. J. Pharmacol, 311 R7-8 (1996)
19. 19. G.C. ROSSI, L. LEVENTHAL, E. BOLAN, G.W. PASTERNAK, J. Pharmac. Exp. Ther, 282 858-65 (1997).
20. 20. K. ERB, J.T. LEIBEL, I. TEGEDER, H.U. ZEILHOFER, K. BRUNE, G. GEISSLINGER, Neuroreport, 8 1967-70 (1997).
21. 21. T. YAMAMOTO, N. NOZAKI-TAGUCHI, S. KIMURA, Neurosci, 81 249-54 (1997).
22. 22. JH. Tian, W. Xu, Y. Fang, JS. Mogil, JE. Grisel, DK. Grandy, JS. Han, Br. J. Pharmacol. 120 676-80 (1997).
23. 23. P.G. GILLBERG, S.M. AQUILONIUS, Acta. Neurol. Scand, 72 299-306 (1985)
24. 24. B.J. PLEUVRY, M.A. TOBIAS, Br. J. Pharmacol, 43 706-14 (1971).
25. 25. T.J. YAKSH, R. DIRKSEN, G.J. HARTY, Eur. J. Pharma, 117 81-85 (1985).
26. 26. F.C. TULUNAY, I. YANO, A.E. TAKIMORI, Eur. J. Pharmacol, 35 285-92 (1976).
27. 27. R. DIRKSEN, G.M. NIJHUIS, Eur. J. Pharmacol, 91 215-21 (1983).